X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Natco Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE NATCO PHARMA SUVEN LIFE/
NATCO PHARMA
 
P/E (TTM) x 19.8 24.1 82.2% View Chart
P/BV x 3.7 18.3 20.1% View Chart
Dividend Yield % 1.0 0.6 162.7%  

Financials

 SUVEN LIFE   NATCO PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
NATCO PHARMA
Mar-14
SUVEN LIFE/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs339877 38.6%   
Low Rs144424 34.1%   
Sales per share (Unadj.) Rs39.2223.4 17.6%  
Earnings per share (Unadj.) Rs7.531.1 24.0%  
Cash flow per share (Unadj.) Rs8.840.3 21.8%  
Dividends per share (Unadj.) Rs2.005.00 40.0%  
Dividend yield (eoy) %0.80.8 107.7%  
Book value per share (Unadj.) Rs49.0219.5 22.3%  
Shares outstanding (eoy) m127.2833.07 384.9%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x6.22.9 211.4%   
Avg P/E ratio x32.420.9 154.6%  
P/CF ratio (eoy) x27.516.1 170.4%  
Price / Book Value ratio x4.93.0 166.3%  
Dividend payout %26.816.1 166.5%   
Avg Mkt Cap Rs m30,73221,504 142.9%   
No. of employees `0001.0NA-   
Total wages/salary Rs m4161,128 36.9%   
Avg. sales/employee Rs Th5,236.1NM-  
Avg. wages/employee Rs Th436.5NM-  
Avg. net profit/employee Rs Th995.5NM-  
INCOME DATA
Net Sales Rs m4,9957,389 67.6%  
Other income Rs m194167 115.8%   
Total revenues Rs m5,1897,556 68.7%   
Gross profit Rs m1,2331,793 68.7%  
Depreciation Rs m167304 54.9%   
Interest Rs m54366 14.8%   
Profit before tax Rs m1,2051,290 93.4%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255309 82.6%   
Profit after tax Rs m9501,027 92.4%  
Gross profit margin %24.724.3 101.7%  
Effective tax rate %21.223.9 88.4%   
Net profit margin %19.013.9 136.7%  
BALANCE SHEET DATA
Current assets Rs m4,9863,681 135.4%   
Current liabilities Rs m1,0423,123 33.4%   
Net working cap to sales %79.07.6 1,044.4%  
Current ratio x4.81.2 405.8%  
Inventory Days Days6189 68.2%  
Debtors Days Days3959 66.7%  
Net fixed assets Rs m3,1267,685 40.7%   
Share capital Rs m127331 38.5%   
"Free" reserves Rs m3,7176,670 55.7%   
Net worth Rs m6,2367,259 85.9%   
Long term debt Rs m432955 45.3%   
Total assets Rs m8,07911,957 67.6%  
Interest coverage x23.24.5 513.6%   
Debt to equity ratio x0.10.1 52.7%  
Sales to assets ratio x0.60.6 100.1%   
Return on assets %12.411.7 106.6%  
Return on equity %15.214.2 107.6%  
Return on capital %18.920.7 91.1%  
Exports to sales %87.539.4 222.3%   
Imports to sales %12.25.7 214.5%   
Exports (fob) Rs m4,3712,908 150.3%   
Imports (cif) Rs m611421 145.0%   
Fx inflow Rs m4,6663,445 135.4%   
Fx outflow Rs m942703 134.1%   
Net fx Rs m3,7242,743 135.8%   
CASH FLOW
From Operations Rs m9221,440 64.0%  
From Investments Rs m-619-1,089 56.9%  
From Financial Activity Rs m-698-353 198.0%  
Net Cashflow Rs m-396-1 26,557.0%  

Share Holding

Indian Promoters % 63.4 52.0 121.8%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 0.0 16.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 26.0 140.4%  
Shareholders   37,287 25,395 146.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   FDC LTD.  UNICHEM LAB  WYETH LTD  ELDER PHARMA  ALEMBIC LTD  

Compare SUVEN LIFE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 16, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - DIVIS LABORATORIES COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS